CLINICAL_TRIALS
trial_result
· 2024-06-21
Clinical Trial Update: A Study of TEPEZZA® Treatment in Participants With Thyroid Eye Disease [Phase 1]
Summary
Phase 1 study evaluating TEPEZZA in participants with Thyroid Eye Disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Thyroid Eye Disease | Phase 1 | Status: COMPLETED